Brussels 2007 Roundtable on Metabolism in Sepsis and Multiple Organ Failure

Abstract

At the 2007 International Symposium on Intensive Care and Emergency Medicine (ISICEM) in Brussels, a roundtable conference on “Metabolic Support in Sepsis and Multiple Organ Failure” was held. The roundtable was endorsed by the European Society of Intensive Care Medicine, the Society of Critical Care Medicine, the European Society for Clinical Nutrition and Metabolism, and the American Society for Parenteral and Enteral Nutrition. Metabolic support in intensive care has become an exciting topic in recent years, with improved understanding of the effects of compromised mitochondrial function, studies demonstrating outcome benefits of tight glucose control, new insights into the mechanisms behind insulin resistance, recognition of glutamine and antioxidants as key nutrients, and emerging knowledge concerning the interactions between metabolism and endocrinology. Together, these aspects have generated an increased interest in the importance of metabolism in intensive care medicine, reflected in the programs and abstracts at international congresses of the past few years. This roundtable's participants each gave a presentation within their specific area of expertise, and each was followed by general discussion. Discussions became heated as new concepts and ideas were debated. New data will be discussed in this summary which reveals metabolic and nutrition interventions that could lead to major improvements in clinically relevant outcomes.

At the March 2007 International Symposium on Intensive Care and Emergency Medicine (ISICEM), thirty speakers from Europe and North America participated in presentations and discussions on metabolism in sepsis and multiple organ failure. This is a brief report on that roundtable.

Get full access to this article

View all access options for this article.

References

Brealey D, Karyampudi S, Jacques T, et al. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol. 2004 ;286:R491– R497.

Fredriksson K, Hammarqvist F, Strigard K, et al. Derangements in mitochondrial metabolism in intercostal and leg muscle of critically ill patients with sepsis induced multiple organ failure. Am J Physiol Endocrinol Metab. 2006;291:E1044– 1050.

Rigoulet M, Leverve X, Fontaine E, Ouhabi R, Guerin B. Quantitative analysis of some mechanisms affecting the yield of oxidative phosphorylation: dependence upon both fluxes and forces. Mol Cell Biochem. 1998 ;184:35– 52.

Macias CA, Chiao JW, Xiao J, et al. Treatment with a novel hemigramicidin-TEMPO conjugate prolongs survival in a rat model of lethal HS.Ann Surg. 2007;245:305– 314.

Levy RJ, Vijayasarathy C, Raj NR, Avadhani NG, Deutschman CS. Competitive and noncompetitive inhibition of myocardial cytochrome C oxidase in sepsis. Shock. 2004;21:110– 114.

Larsson L, Li X, Edstrom L, et al. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels.Crit Care Med. 2000;28:34– 45.

Sugita H, Fujimoto M, Yasukawa T, et al. Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells. J Biol Chem. 2005 ;280:14203– 14211.

Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical ICU: benefit versus harm.Diabetes. 2006;55:3151– 3159.

Devos P, Preiser JC. Tight blood glucose control: a recommendation applicable to any critically ill patient? Crit Care. 2004 ;8:427– 429.

10.

Träger K, Leverve X, Radermacher P. The adrenergic coin: perfusion and metabolism. Intensive Care Med. 2003 ;29:150– 153.

11.

Jeschke MG, Klein D, Herndon DN. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg. 2004 ;239:553– 560.

12.

Tappy L, Berger MM, Schwarz JM, et al. Metabolic effects of parenteral nutrition enriched with n-3 polyunsaturated fatty acids in critically ill patients Clin Nutr. 2006 ;25:588– 595.

13.

Heyland DK, Dhaliwal R, Drover JW, Gramlich L, Dodek P. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr. 2003 ;27:355– 373.

14.

Singleton KD, Serkova N, Beckey VE, Wischmeyer PE. Glutamine attenuates lung injury and improves survival after sepsis: role of enhanced heat shock expression. Crit Care Med. 2005 ;33:1206– 1213.

15.

Ziegler TR, Ogden LG, Singleton KD, et al. Parenteral glutamine increases serum heat shock protein 70 in critically ill patients.Intensive Care Med. 2005;31 :1079– 1086.

16.

Griffiths RD, Allen KD, Andrews FJ, Jones C. Infection, multiple organ failure, and survival in the intensive care unit: influence of glutamine-supplemented parenteral nutrition on acquired infection.Nutrition. 2002;18:546– 552.

17.

Berg A, Rooyackers O, Norberg A, Wernerman J. Elimination kinetics of L-alanyl-L-glutamine in ICU patients. Amino Acids. 2005 ;29:221– 228.

18.

Abumrad NN, Barbul A. The use of arginine in clinical practice. In: Cynober L, ed. Amino Acid Metabolism and Therapy in Health and Nutritional Diseases. Boca Raton, FL: CRC Press; 2003:595– 611.

19.

Boelens PG, van Leeuwen PA, Dejong CH, Deutz NE. Intestinal renal metabolism of L-citrulline and L-arginine following enteral or parenteral infusion of L-alanyl-L-[2,15N]glutamine or L-[2,15N]glutamine in mice.Am J Physiol Gastrointest Liver Physiol. 2005 ;289:G679– G685.

20.

McGregor GP, Biesalski HK. Rationale and impact of vitamin C in clinical nutrition. Curr Opinion Clin Nutr Metabol Care. 2006 ; 9:697– 703.

21.

Berger MM, Eggimann P, Heyland DK, et al. Reduction of nosocomial pneumonia after major burns by trace element supplementation: aggregation of two randomized trials [abstract]. Crit Care.2006 ;10:R153 .

22.

Biolo G, Heer M, Narici M, Strollo F. Microgravity as a model of ageing. Curr Opin Clin Nutr Metab Care. 2003 ;6:31– 40.

23.

Annane D, Maxime V, Ibrahim F, Alvarez JC, Abe E, BouDou P. Diagnosis of adrenal insufficiency in severe sepsis and septic shock.Am J Respir Crit Care Med. 2006 ;174:1319– 1326.

24.

Van den Berghe G, Baxter RC, Weekers F, et al. The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clin Endocrinol (Oxf). 2002 ;56:655– 669.

25.

Yang H, Wei W, Menconi M, Hasselgren PO. Dexamethasone-induced protein degradation in cultured myotubes is p300/HAT dependent. Am J Physiol Regul Integr Comp Physiol. 2007 ;292:R337 .

26.

Russell JA. Vasopressin in septic shock: clinical equipoise mandates a time for restraint. Crit Care Med. 2003 ;31:2707– 2709.

27.

Herndon DN, Hart DW, Wolf SE, Chinkes DL, Wolfe RR. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med. 2001 ;345:1223– 1229.

28.

Hildebrand F, Hubbard WJ, Choudhry MA Thobe BM, Pape HC, Chaudry IH. Are the protective effects of 17beta-estradiol on splenic macrophages and splenocytes after trauma-hemorrhage mediated via estrogen-receptor (ER)-alpha and ER-beta? J Leukoc Biol. 2006 ;79:1173– 1180.

29.

Hart DW, Wolf SE, Ramzy PI, et al. Anabolic effects of oxandrolone after severe burn. Ann Surg. 2001 ;233:556– 564.

30.

Przkora R, Jeschke MG, Barrow RE, et al. Metabolic and hormonal changes of severely burned children receiving long-term oxandrolone treatment.Ann Surg. 2005;242:384– 391.